Skip to main content

12 August 2022

WuXi Advanced Therapies: All in the Genes


Editorial /Business Focus/12 August 2022

Download PDF – 12.6 MB


WuXi Advanced Therapies is the advanced therapies business unit of WuXi AppTec, with a globally integrated, full value chain operational model working to serve clients in the cell and gene therapy sectors. With four sites on three continents, WuXi Advanced Therapies has a presence in the US, China, and the UK, operating as a Contract Testing, Development and Manufacturing Organization (CTDMO).

The company serves as an innovator, with full in-house development and manufacturing capabilities. Its goal is to solve today’s commercialisation challenges by leveraging over 30 years of experience and expertise to deliver the biopharmaceuticals of tomorrow.

Download the resource to continue reading.